Literature DB >> 2426259

Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand.

R Laufer, C Gilon, M Chorev, Z Selinger.   

Abstract

We have recently characterized a tachykinin receptor subtype (SP-N) whose preferred ligand is the mammalian neuropeptide, neurokinin B (Laufer, R., Wormser, U., Friedman, Z. Y., Gilon, C., Chorev, M., and Selinger, Z. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 7444-7448). To investigate this novel tachykinin receptor, we have now prepared a radiolabeled peptide, N alpha-[( 125I]desamino-3-iodotyrosyl)-[Asp5,6, N-methyl-Phe8]substance P (5-11) heptapeptide (125I-BH-NH-Senktide), which selectively interacts with the SP-N receptor subtype. The binding of 125I-BH-NH-Senktide to rat cerebral cortex membranes was studied under conditions that minimized nonspecific binding. Unlike other tachykinin receptor probes, this radioligand is not degraded during the binding experiment. Binding of 125I-BH-NH-Senktide is reversible, saturable, and of high affinity (KD = 0.9 nM). The radioligand labels a single class of binding site (122 fmol binding sites/mg of protein), as indicated by a linear Scatchard plot and a Hill coefficient close to unity (nH = 1.05). The pharmacological specificity of this binding site corresponds to that of the neuronal SP-N receptor in guinea pig ileum myenteric plexus, which was determined by a functional bioassay. Among various rat brain regions, the highest binding was observed in the cerebral cortex, olfactory bulb, hypothalamus, and hippocampus. These results suggest the existence and specific distribution of a neurokinin B receptor site of the SP-N type in rat brain. 125I-BH-NH-Senktide is the first selective and potent probe for this receptor and is thus an important tool for further studies of its distribution, regulation, and functional role.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.

Authors:  J Alberch; E Arenas; E Pérez-Navarro; J Marsal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.

Authors:  O Ploux; S Lavielle; G Chassaing; S Julien; A Marquet; P d'Orléans-Juste; S Dion; D Regoli; J C Beaujouan; L Bergström
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.

Authors:  S Guard; S P Watson; J E Maggio; H P Too; K J Watling
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

5.  Comparison of the binding of radiolabelled neurokinin A and eledoisin in rat cortex synaptic membranes.

Authors:  A C Foster; R Tridgett
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

6.  Tachykininergic transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of NK2 receptors.

Authors:  L Bartho; P Santicioli; R Patacchini; C A Maggi
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

7.  1H nuclear magnetic resonance determination of the membrane-bound conformation of senktide, a highly selective neurokinin B agonist.

Authors:  B Bersch; P Koehl; Y Nakatani; G Ourisson; A Milon
Journal:  J Biomol NMR       Date:  1993-07       Impact factor: 2.835

8.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 9.  Current and future applications of GnRH, kisspeptin and neurokinin B analogues.

Authors:  Robert P Millar; Claire L Newton
Journal:  Nat Rev Endocrinol       Date:  2013-07-02       Impact factor: 43.330

10.  Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.

Authors:  A Floch; V Fardin; I Cavero
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.